z-logo
open-access-imgOpen Access
Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum]
Author(s) -
Xuguang Li,
Weirun Chen,
Kaihang Liu,
Sheng Zhang,
Ru Yang,
Kairui Liu,
Dateng Li,
Youxing Huang
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s310256
Subject(s) - sorafenib , hepatocellular carcinoma , cancer research , protein kinase b , medicine , pharmacology , oncology , signal transduction , biology , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom